COMMUNIQUÉS West-GlobeNewswire

-
Eascra Biotech Preparing for a Fifth Flight to the International Space Station
16/04/2025 -
Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis
16/04/2025 -
Dyadic to Present at World Vaccine Congress | Washington
16/04/2025 -
Basilea shareholders approve all proposals of the board of directors at the annual general meeting
16/04/2025 -
Spineway : First-quarter 2025 revenue of €2.8 million
16/04/2025 -
SPINEWAY : Chiffre d’affaires du 1er trimestre 2025 de 2,8 M€
16/04/2025 -
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
16/04/2025 -
Correction: Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l’exercice 2025
16/04/2025 -
Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®
16/04/2025 -
Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress dont une présentation sur son vaccin contre le chikungunya IXCHIQ®
16/04/2025 -
First Steroid Cycle: Beginner’s Guide to Bulking & Cutting + (Before And After Result ) - 2025 - By CrazyBulk in USA
16/04/2025 -
Ivy En Rose MedSpa and The Junior League of San Francisco Announce New Date For Their Partnered Event, To Be Held on May 20, 2025
16/04/2025 -
Olon Receives 2025 CMO Excellence in Green Chemistry Award
16/04/2025 -
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES
16/04/2025 -
Closest Things to Steroids 2025: Safe & Legal Substitute for Muscle Growth & Bodybuilding - Legal Alternatives By CrazyBulk USA
16/04/2025 -
Sabin Begins Marburg Vaccine Trial in U.S.
16/04/2025 -
Best Oral Steroids 2025 - Bodybuilding Steroids for Muscle Growth, Strength & Huge Size - Bodybuilders' #1 Picks - By CrazyBulk USA
16/04/2025 -
Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment
16/04/2025 -
Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023
16/04/2025
Pages